Your browser is no longer supported. Please, upgrade your browser.
Settings
PKI [NYSE]
PerkinElmer, Inc.
IndexS&P 500 P/E19.45 EPS (ttm)6.48 Insider Own0.20% Shs Outstand111.68M Perf Week-7.82%
Market Cap14.11B Forward P/E20.11 EPS next Y6.27 Insider Trans-19.78% Shs Float111.00M Perf Month-11.04%
Income728.10M PEG1.13 EPS next Q2.99 Inst Own96.40% Short Float2.13% Perf Quarter-0.77%
Sales3.78B P/S3.73 EPS this Y-2.70% Inst Trans2.97% Short Ratio2.56 Perf Half Y5.57%
Book/sh28.94 P/B4.36 EPS next Y-30.67% ROA4.40% Target Price164.86 Perf Year49.54%
Cash/sh2.31 P/C54.61 EPS next 5Y17.20% ROE10.00% 52W Range62.91 - 162.70 Perf YTD-12.13%
Dividend0.28 P/FCF34.20 EPS past 5Y7.70% ROI6.50% 52W High-22.50% Beta1.12
Dividend %0.22% Quick Ratio1.00 Sales past 5Y5.20% Gross Margin55.80% 52W Low100.43% ATR4.78
Employees13000 Current Ratio1.30 Sales Q/Q36.40% Oper. Margin10.70% RSI (14)29.57 Volatility3.49% 3.57%
OptionableYes Debt/Eq0.57 EPS Q/Q199.60% Profit Margin7.80% Rel Volume1.33 Prev Close125.97
ShortableYes LT Debt/Eq0.46 EarningsFeb 02 AMC Payout10.50% Avg Volume924.86K Price126.09
Recom2.20 SMA20-11.34% SMA50-13.18% SMA2002.06% Volume1,224,696 Change0.10%
Jan-07-21Upgrade Wells Fargo Equal Weight → Overweight $175
Dec-02-20Initiated Goldman Buy $160
Nov-10-20Initiated KeyBanc Capital Markets Sector Weight $150
Nov-09-20Reiterated Needham Buy $139 → $193
Sep-11-20Upgrade Needham Hold → Buy $139
Jul-29-20Upgrade CFRA Hold → Buy
Jan-08-20Initiated Wells Fargo Equal Weight $105
Jan-07-20Initiated Citigroup Neutral $100
Jan-02-20Upgrade Evercore ISI In-line → Outperform
Nov-15-19Initiated Stifel Buy
Oct-31-19Downgrade Piper Jaffray Overweight → Neutral $104 → $89
Sep-26-19Upgrade BofA/Merrill Neutral → Buy $105
May-30-19Initiated Wolfe Research Peer Perform
Apr-09-19Upgrade Goldman Neutral → Buy $115
Jan-03-19Initiated Needham Hold
Nov-02-18Downgrade Janney Buy → Neutral
Oct-09-18Initiated UBS Neutral
Sep-10-18Reiterated Deutsche Bank Hold $88 → $93
Dec-19-17Upgrade BofA/Merrill Underperform → Neutral
Sep-26-17Resumed Goldman Neutral $67
Feb-26-21 08:00AM  
Feb-23-21 08:00AM  
Feb-22-21 08:30AM  
Feb-16-21 08:00AM  
07:00AM  
Feb-09-21 03:29PM  
Feb-05-21 11:09AM  
06:30AM  
12:25AM  
Feb-04-21 12:25PM  
09:30AM  
09:29AM  
09:22AM  
Feb-03-21 04:32PM  
11:23AM  
09:48AM  
07:31AM  
06:00AM  
Feb-02-21 05:55PM  
04:30PM  
04:05PM  
02:45PM  
08:45AM  
Feb-01-21 10:05AM  
Jan-29-21 05:47AM  
Jan-28-21 04:15PM  
Jan-27-21 10:13AM  
09:44AM  
Jan-26-21 12:31PM  
Jan-22-21 09:28AM  
06:29AM  
Jan-21-21 12:45PM  
12:10PM  
10:14AM  
Jan-20-21 06:03PM  
11:36AM  
09:10AM  
08:42AM  
Jan-19-21 09:16AM  
Jan-18-21 10:08AM  
09:41AM  
06:20AM  
Jan-15-21 10:25AM  
Jan-14-21 09:56AM  
08:15AM  
08:00AM  
Jan-13-21 11:15AM  
Jan-12-21 11:41AM  
Jan-11-21 09:55AM  
09:48AM  
06:10AM  
06:00AM  
Jan-08-21 11:30AM  
Jan-07-21 04:25PM  
12:34PM  
07:00AM  
Jan-06-21 12:43PM  
Jan-05-21 06:55AM  
Dec-24-20 07:47AM  
Dec-21-20 02:14PM  
Dec-17-20 11:30AM  
Dec-16-20 08:00AM  
Dec-12-20 03:44AM  
Dec-11-20 09:43AM  
Dec-09-20 12:00PM  
Dec-08-20 10:44AM  
09:33AM  
Dec-07-20 12:45PM  
12:05PM  
Dec-01-20 11:30AM  
Nov-30-20 10:42AM  
Nov-20-20 12:45PM  
08:12AM  
Nov-17-20 08:13AM  
08:00AM  
Nov-16-20 11:00AM  
Nov-12-20 08:00AM  
Nov-10-20 11:30AM  
07:24AM  
Nov-09-20 09:36AM  
08:00AM  
Nov-06-20 09:32AM  
Nov-05-20 12:20PM  
08:00AM  
Nov-04-20 12:45PM  
11:00AM  
08:00AM  
Nov-02-20 04:35PM  
12:00PM  
02:05AM  
Oct-29-20 04:05PM  
07:56AM  
12:31AM  
Oct-28-20 04:05PM  
03:00PM  
Oct-27-20 08:31AM  
Oct-26-20 08:00AM  
Oct-23-20 11:30AM  
Oct-22-20 04:15PM  
08:58AM  
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. The company operates in two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterization and health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophym, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology and drug discovery. The company serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Tereau Daniel RPlease See RemarksFeb 01Option Exercise81.292,047166,40111,118Feb 02 05:56 PM
Tereau Daniel RPlease See RemarksFeb 01Sale147.072,047301,0529,071Feb 02 05:56 PM
Goldberg Joel SPlease See RemarksJan 06Option Exercise46.2625,1491,163,26796,924Jan 07 04:33 PM
Goldberg Joel SPlease See RemarksJan 06Sale155.5225,1493,911,18271,775Jan 07 04:33 PM
Singh Prahlad R.Please See RemarksJan 05Option Exercise46.2610,636491,96850,537Jan 07 04:59 PM
Goldberg Joel SPlease See RemarksJan 05Option Exercise46.261,15853,56373,293Jan 07 04:33 PM
Goldberg Joel SPlease See RemarksJan 05Sale152.511,518231,51171,775Jan 07 04:33 PM
Singh Prahlad R.Please See RemarksJan 05Sale150.0010,6361,595,40039,901Jan 07 04:59 PM
Tereau Daniel RPlease See RemarksDec 14Option Exercise81.294,094332,80111,521Dec 15 04:10 PM
Tereau Daniel RPlease See RemarksDec 14Sale146.684,094600,5087,427Dec 15 04:10 PM
Okun AndrewPlease See RemarksNov 06Option Exercise81.296,107496,43816,417Nov 09 04:05 PM
Okun AndrewPlease See RemarksNov 06Sale140.146,107855,83510,310Nov 09 04:05 PM
Mock James MPlease See RemarksOct 02Sale124.415,623699,58427,218Oct 05 04:05 PM
Goldberg Joel SPlease See RemarksJul 31Option Exercise43.0123,3871,005,87595,179Aug 03 04:05 PM
Goldberg Joel SPlease See RemarksJul 31Sale117.8423,3872,755,82571,792Aug 03 04:05 PM
Okun AndrewPlease See RemarksJul 29Option Exercise52.654,699247,40217,009Jul 30 06:42 PM
Okun AndrewPlease See RemarksJul 29Sale120.006,699803,88010,310Jul 30 06:42 PM
Tereau Daniel RPlease See RemarksJun 15Option Exercise43.743,242141,78912,879Jun 16 04:06 PM
Tereau Daniel RPlease See RemarksJun 15Sale95.225,452519,1397,427Jun 16 04:06 PM
Barrett PeterDirectorMay 28Option Exercise42.094,750199,90429,552May 29 04:06 PM
Barrett PeterDirectorMay 28Sale100.117,552756,03822,001May 29 04:06 PM